Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an update.
Wai Chun Bio-Technology Ltd. has announced a revised timetable for its proposed capital reorganization and the alteration of terms for existing convertible bonds. The company has received court approval for the capital reduction but requires additional time for registration, leading to a new expected effective date of October 28, 2025. This reorganization is crucial for the company’s financial structuring and may impact shareholder engagement and market positioning.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. The company is listed on the Stock Exchange of Hong Kong and is involved in capital reorganization and financial transactions related to convertible bonds.
Average Trading Volume: 404,906
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.98M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.